49 related articles for article (PubMed ID: 34454048)
1. Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer.
Song W; Kim LC; Han W; Hou Y; Edwards DN; Wang S; Blackwell TS; Cheng F; Brantley-Sieders DM; Chen J
Mol Cancer Res; 2020 Nov; 18(11):1735-1743. PubMed ID: 32753469
[TBL] [Abstract][Full Text] [Related]
2. Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes.
Liu Y; Bunney TD; Khosa S; Macé K; Beckenbauer K; Askwith T; Maslen S; Stubbs C; de Oliveira TM; Sader K; Skehel M; Gavin AC; Phillips C; Katan M
EBioMedicine; 2020 Jan; 51():102607. PubMed ID: 31918402
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of phospholipase Cγ in immune disorders and cancer.
Koss H; Bunney TD; Behjati S; Katan M
Trends Biochem Sci; 2014 Dec; 39(12):603-11. PubMed ID: 25456276
[TBL] [Abstract][Full Text] [Related]
4. Cancer as a Disease of Development Gone Awry.
Stanger BZ; Wahl GM
Annu Rev Pathol; 2024 Jan; 19():397-421. PubMed ID: 37832945
[TBL] [Abstract][Full Text] [Related]
5. Systems pharmacodynamic model of combined gemcitabine and trabectedin in pancreatic cancer cells. Part I.Çô Effects on signal transduction pathways related to tumor growth.
Miao X; Shen S; Koch G; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):214-227. PubMed ID: 38498417
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.
Roh TH; Chae MK; Ko JS; Kikkawa DO; Jang SY; Yoon JS
Endocrinol Metab (Seoul); 2023 Dec; 38(6):739-749. PubMed ID: 37989267
[TBL] [Abstract][Full Text] [Related]
7. Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review.
Orsini F; Crotti C; Cincinelli G; Di Taranto R; Amati A; Ferrito M; Varenna M; Caporali R
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887030
[TBL] [Abstract][Full Text] [Related]
8. PIP5Kγ Mediates PI(4,5)P2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo-YAP Pathway Regulation.
Le DDT; Le TPH; Lee SY
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834234
[TBL] [Abstract][Full Text] [Related]
9. A gain-of-function variation in PLCG1 causes a new immune dysregulation disease.
Tao P; Han X; Wang Q; Wang S; Zhang J; Liu L; Fan X; Liu C; Liu M; Guo L; Lee PY; Aksentijevich I; Zhou Q
J Allergy Clin Immunol; 2023 Nov; 152(5):1292-1302. PubMed ID: 37422272
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches.
Salucci S; Aramini B; Bartoletti-Stella A; Versari I; Martinelli G; Blalock W; Stella F; Faenza I
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370855
[TBL] [Abstract][Full Text] [Related]
11. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
[TBL] [Abstract][Full Text] [Related]
12. A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients.
Xiao X; Li J; Wan S; Wu M; Li Z; Tian J; Mi J
Front Genet; 2022; 13():1006151. PubMed ID: 36386841
[No Abstract] [Full Text] [Related]
13. Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective.
Puccini A; Seeber A; Berger MD
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230751
[TBL] [Abstract][Full Text] [Related]
14. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?
Lengyel CG; Hussain S; Seeber A; Jamil Nidhamalddin S; Trapani D; Habeeb BS; Elfaham E; Mazher SA; Seid F; Khan SZ; El Bairi K; Odhiambo A; Altuna SC; Petrillo A
Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054474
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis.
Mandal S; Bandyopadhyay S; Tyagi K; Roy A
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188619. PubMed ID: 34454048
[TBL] [Abstract][Full Text] [Related]
16. PLCγ1: Potential arbitrator of cancer progression.
Jang HJ; Suh PG; Lee YJ; Shin KJ; Cocco L; Chae YC
Adv Biol Regul; 2018 Jan; 67():179-189. PubMed ID: 29174396
[TBL] [Abstract][Full Text] [Related]
17. DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.
Dai L; Zhuang L; Zhang B; Wang F; Chen X; Xia C; Zhang B
Int J Mol Sci; 2015 Dec; 16(12):28510-22. PubMed ID: 26633375
[TBL] [Abstract][Full Text] [Related]
18. A phosphoinositide 3-kinase/phospholipase Cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation.
Maffucci T; Raimondi C; Abu-Hayyeh S; Dominguez V; Sala G; Zachary I; Falasca M
PLoS One; 2009 Dec; 4(12):e8285. PubMed ID: 20011604
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells
Lu X; Fu H; Chen R; Wang Y; Zhan Y; Song G; Hu T; Xia C; Tian X; Zhang B
Int J Biol Sci; 2020; 16(8):1427-1440. PubMed ID: 32210730
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
